Literature DB >> 3235565

Determination of halofantrine and its principal metabolite desbutylhalofantrine in biological fluids by reversed-phase high-performance liquid chromatography.

K A Milton1, S A Ward, G Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235565     DOI: 10.1016/s0378-4347(00)80618-0

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  7 in total

1.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Pharmacokinetics of halofantrine in man: effects of food and dose size.

Authors:  K A Milton; G Edwards; S A Ward; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

3.  An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.

Authors:  R C Halliday; B C Jones; D A Smith; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

4.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

5.  Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.

Authors:  J Karbwang; K A Milton; K Na Bangchang; S A Ward; G Edwards; D Bunnag
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 6.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.